I am amazed of how much have you study the walk forward!
I never had tried so many combinations IS/OOS.
I haven't thought it very much, but so many combinatios.. smells like curve 
fitting..

But I have a very simple doubt: what steps doy you use?
I think Howard Bandy says that the step could be very small, probably better if 
smaller.

So I use steps of 1 month with stocks, whatever the IS and OOS perios are.

By the way.. so many combinations IS/OOS.. how much time have you been testing?
For, my PC last nearly 2 hours to finish a 10-years WF study.. 
many studies, is a many days-long job?

--- In [email protected], "Ton Sieverding" <ton.sieverd...@...> wrote:
>
> Thanks again Mike ... See also my previous answer. Just one more remark. Here 
> you are suggesting to take 1 to 3 year for the OOS period. When using 
> commodity time series, this is more or less what I am doing. Why ? Because a 
> lot of commodities coming from the agricultural sector have these typical 
> yearly cycles. But when using time series based upon stocks ( S&P500 etc. ), 
> I am using a 5 to 7 year OOS period. Simply because of the economic cycle. I 
> am telling you this because it shows how I am thinking. Just taking a period 
> because somebody gave me a rule of thumb is rather tricky in my eyes. For me 
> there must be a good explanation for the length of that period ...
> 
> Regards, Ton.
> 
> 
>   ----- Original Message ----- 
>   From: Mike 
>   To: [email protected] 
>   Sent: Monday, October 05, 2009 11:32 AM
>   Subject: [amibroker] Re: Is the Walk forward study useful?
> 
> 
>     Ton,
> 
>   You said "If you can help me to get things done in an objective way then I 
> will be delighted to know how you want to do that"
> 
>   What I was suggesting was:
> 
>   1. Identify what measure you will use to judge the IS/OOS period sizes 
> (i.e. in my case I used consistency of CAR).
> 
>   2. Run walk forward with IS ranging from 1 year to 3 years and OOS ranging 
> from 1/8 to 1/3 of the IS period.
> 
>   3. Calculate summary statistics for each IS/OOS combination for the measure 
> that you decided upon in step 1 (i.e. in my case I calculated the average CAR 
> and the standard deviation of CAR from the OOS samples). It may help to plot 
> a distribution to visualize the data.
> 
>   4. Observe whether one IS/OOS combination stands out as having the most 
> normally distributed values.
> 
>   Naturally, there is a limit to how many IS/OOS combinations we can try 
> before we have curve fit our results. This is where I find Pardo's ratios to 
> be helpful. By keeping within the suggested range, we are leaving untested 
> many alternative combinations.
> 
>   Mike
> 
>   --- In [email protected], "Mike" <sfclimbers@> wrote:
>   >
>   > Ton,
>   > 
>   > 1. Pardo disagrees with Aronson (and Bandy). Pardo suggests that a OOS to 
> IS ration of 25% - 35% is best, but that a good rule of thumb for empirical 
> testing is 1/8 to 1/3. 
>   > 
>   > 2. Yes, I suspect that each strategy will have its own best values for 
> IS/OOS and that other values will appear as useless. It is up to us to try 
> and find the best values.
>   > 
>   > With respect to your comment: "I am getting results that show a random 
> pattern", my question remains; What are you measuring? In other words, what 
> values appear random - your fitness value? CAR? Something else?
>   > 
>   > 3. I have done very much as you ask, except that I also varied my IS 
> period. I mostly kept my ratios within Pardo's suggested 1/8 to 1/3, but went 
> as low as 1/12 and as high as 1/2 just to be sure.
>   > 
>   > For example IS=1 year, IS=2 years, IS=3 years giving
>   > 
>   > IS1yr+OOS6mth, IS1yr+OOS3mth, IS1yr+OOS1mth
>   > IS2yr+OOS12mth, IS2yr+OOS6mth, IS2yr+OOS3mth
>   > IS3yr+OOS18mth, IS3yr+OOS12mth, IS3yr+OOS6mth
>   > 
>   > IS2yr+OOS6mth produced the most consistent CAR, even though a weighted 
> UPI was used as the fitness function for the actual walk forward.
>   > 
>   > I do not have a strong opinion as to whether or not there really is a 
> relationship between IS and OOS sizes. I found that Pardo's rule of thumb was 
> as good a starting place as any. I was happy that my values (25%) coincided 
> with what he advised. But, had my studies suggested a ratio outside of 
> Pardo's range, I would have still gone with what my results suggested, 
> despite Pardo's advice.
>   > 
>   > Mike
>   > 
>   > --- In [email protected], "Ton Sieverding" <ton.sieverding@> 
> wrote:
>   > >
>   > > Hi Mike,
>   > > 
>   > > What I am saying is :
>   > > 
>   > > 1. That according to David Aronson "There is no theory that suggests 
> what fraction of the data should be assigned to training ( IS ) and testing ( 
> OOS )." and that "Results can be very sensitive to these choices ... ". I 
> assume that he knows where he is talking about ...
>   > > 
>   > > 2. That when I am doing WalkFoward tests following the advice of Howard 
> Bandy, Robert Pardo AND Van Tharp, I am getting results that show a random 
> patron when changing the OOS en IS periods. So my conclusion is that 
> WalkFoward is a subjective test ...
>   > > 
>   > > Therefore I have serious problems using WalkFoward tests. If you can 
> help me to get things done in an objective way then I will be delighted to 
> know how you want to do that. But for sure Van Tharp did not help me ...
>   > > 
>   > > Please do a simple WF test with OOS=1year and IS=1month...12months. So 
> creating WF results for OOS1y+IS1m, OOS1y+IS2m etc. And see what you are 
> getting. This is purely random. The result says nothing to me ...
>   > > 
>   > > Regards, Ton.
>   > > 
>   > > 
>   > > 
>   > > ----- Original Message ----- 
>   > > From: Mike 
>   > > To: [email protected] 
>   > > Sent: Monday, October 05, 2009 9:29 AM
>   > > Subject: [amibroker] Re: Is the Walk forward study useful?
>   > > 
>   > > 
>   > > Ton,
>   > > 
>   > > Are you saying that you have not found an IS/OOS pair that works well? 
> What measure are you using to judge "stability" of the walk forward process 
> (i.e. what measure are you using to judge the process as random)?
>   > > 
>   > > After testing with multiple IS periods, and with multiple OOS periods, 
> I was able to identify "fixed" window lengths that proved more consistent 
> than the others tested.
>   > > 
>   > > I reached this conclusion by charting a distribution curve of CAR for 
> the OOS results. My fitness function is currently based on UPI, and thus my 
> walk forward is driven by that value. However, ultimately my interest is in 
> how consistent CAR would be which is why I used that for evaluating the 
> goodness of fit for the IS/OOS period lengths.
>   > > 
>   > > In my case, over a 13 year period, a 2 year IS and 6 month OOS (for a 
> total of 26 OOS data points) produced the most normal looking distribution of 
> CAR results (i.e. central peak, smallest standard deviation). Excluding the 
> results from all of 1999 and the first half of 2000 (during which results 
> were abnormally strong), the distribution curve looks even better.
>   > > 
>   > > Also, have you tried working with different fitness functions? Perhaps 
> your fitness function doesn't adequately identify the "signal" and thus 
> misguides the walk forward, regardless of IS/OOS window lengths.
>   > > 
>   > > I am in the process of running a new walk forward over the last 7.5 
> years using Van Tharp's System Quality Number (SQN) as my fitness function. I 
> have kept the same 2 year IS/6 months OOS for a total of 15 OOS data points. 
> My system strives to generate a minimum average of 2 trades per day, so each 
> IS period generally has 1000 or more trades from which to calculate the 
> fitness.
>   > > 
>   > > It has not run to completion yet. But, for the periods that have 
> produced results, the results look promising (at least with respect to the 
> SQN of the OOS relative to the SQN of the IS, I have not yet created the 
> distribution of CAR for OOS).
>   > > 
>   > > Assuming that the remainder of the results are equally strong, I will 
> walk forward further back in history to get the full 26 data points to 
> compare against the results produced using my UPI fitness. If the CAR 
> distribution is more normal using SQN as fitness, then I will officially 
> start using SQN for generating optimal values for my next live OOS.
>   > > 
>   > > If you are willing to share, I would be curious to hear if SQN as a 
> fitness function was able to produce a more stable walk forward for you, and 
> what measure you are using to judge "stable".
>   > > 
>   > > Mike
>   > > 
>   > > --- In [email protected], "Ton Sieverding" <ton.sieverding@> 
> wrote:
>   > > >
>   > > > Hi Howard,
>   > > > 
>   > > > I still am struggling with the following sentence from David Aronson 
> : "The decision about how to apportion the data between the IS and OOS 
> subsets is arbitrary. There is no theory that suggests what fraction of the 
> data should be assigned to training ( IS ) and testing ( OOS ). Results can 
> be very sensitive to these choices ... ". Because this is exactly what I am 
> seeing. WalkFoward results are more then sensitive to the IS/OOS relation and 
> in many cases a pure random story. I am getting more and more the feeling 
> that WalkForward is not the correct or better objective way to test trading 
> systems. With all respect to Robert Pardo's idea's about this topic and what 
> you are writing in QTS ...
>   > > > 
>   > > > Regards, Ton.
>   > > > 
>   > > > 
>   > > > ----- Original Message ----- 
>   > > > From: Howard B 
>   > > > To: [email protected] 
>   > > > Sent: Monday, October 05, 2009 12:48 AM
>   > > > Subject: Re: [amibroker] Re: Is the Walk forward study useful?
>   > > > 
>   > > > 
>   > > > Greetings all --
>   > > > 
>   > > > My point of view on the length of the in-sample and out-of-sample may 
> be a little different.
>   > > > 
>   > > > The logic of the code has been designed to recognize some pattern or 
> characteristic of the data. The length of the in-sample period is however 
> long it takes to keep the model (the logic) in synchronization with the data. 
> There is no one answer to what that length is. When the pattern changes, the 
> model fits it less well. When the pattern changes significantly, the model 
> must be re-synchronized. The only person who can say whether the length is 
> correct or should be longer or shorter is the person running the tests.
>   > > > 
>   > > > The length of the out-of-sample period is however long the model and 
> the data remain in sync. That must be some length of time beyond the 
> in-sample period in order to make profitable trades. It could be a long time, 
> in which case there is no need to modify the model at all during that period. 
> There is no general relationship between the length of the in-sample period 
> and the length of the out-of-sample period -- none. There is no general 
> relationship between the performance in-sample and the performance 
> out-of-sample. The greater the difference between the two, the better the 
> system has been fit to the data over the in-sample period. But that does not 
> necessarily mean that the out-of-sample results are less meaningful.
>   > > > 
>   > > > You can perform some experiments to see what the best in-sample 
> length is. And then to see what the typical out-of-sample length is. Knowing 
> these two, set up a walk forward run using those lengths. After the run is 
> over, ignore the in-sample results. They have no value in estimating the 
> future performance of the system. It is the out-of-sample results that can 
> give you some idea of how the system might act when traded with real money. 
>   > > > 
>   > > > It is nice to have a lot of closed traded in the out-of-sample 
> period, but you can run statistics on as few as 5 or 6. Having fewer trades 
> means that it will be more difficult to achieve statistical significance. The 
> number 30 is not magic -- it is just conventional. 
>   > > > 
>   > > > I think it helps to distinguish between the in-sample and 
> out-of-sample periods this way -- in-sample is seeing how well the model can 
> be made to fit the older data, out-of-sample is seeing how well it might fit 
> future data.
>   > > > 
>   > > > Ignore the television ads where person after person exclaims 
> "backtesting!" as though that is the key to system development. It is not. 
> Backtesting by itself, without going on to walk forward testing, will give 
> the trading system developer the impression that the system is good. 
> In-sample results are always good. We do not stop fooling with the system 
> until they are good. But in-sample results have no value in predicting future 
> performance -- none. 
>   > > > 
>   > > > There are some general characteristics of trading systems that make 
> them easier to validate. Those begin with having a positive expectancy -- no 
> system can be profitable in the long term unless it has a positive 
> expectancy. Then going on to include trade frequently, hold a short time, 
> minimize losses. Of course, there have been profitable systems that trade 
> infrequently, hold a long time, and suffer deep drawdowns. It is much harder 
> to show that those were profitable because they were good rather than lucky.
>   > > > 
>   > > > There is more information about in-sample, out-of-sample, walk 
> forward testing, statistical validation, objective functions, and so forth in 
> my book, "Quantitative Trading Systems."
>   > > > http://www.quantitativetradingsystems.com/ 
>   > > > 
>   > > > Thanks for listening,
>   > > > Howard
>   > > > 
>   > > > 
>   > > > 
>   > > > On Sun, Oct 4, 2009 at 10:56 AM, Bisto <bistoman73@> wrote:
>   > > > 
>   > > > 
>   > > > Yes, I believe that you should increase the IS period
>   > > > 
>   > > > as general rule is not true "the shortest the best" trying to catch 
> every market change because it's possible that a too short IS period produces 
> a too low number of trades with no statistical robustness --> you will find 
> parameters that are more likely candidated to fail in OS
>   > > > 
>   > > > try a longer IS period and let's see what will happen
>   > > > 
>   > > > I read an interesting book on this issue: "The evaluation and 
> optimization of trading strategies" by Pardo. Maybe he repeated too much 
> times the same concepts nevertheless I liked it
>   > > > 
>   > > > if anyone could suggest a better book about this issue it would be 
> very appreciated
>   > > > 
>   > > > 
>   > > > 
>   > > > Bisto
>   > > > 
>   > > > --- In [email protected], "Gonzaga" <gonzagags@> wrote:
>   > > > >
>   > > > > Oh, sorry, I am lost in translation ... ;-)
>   > > > > Yes I meant trades of my IS period.
>   > > > > I've got about 70 trades in my IS period, three months.
>   > > > > BUT, I buy stocks in a multiposition way.This means, that my hole 
> capital divides among several stocks purchased simultaneously.
>   > > > > So, in my statistics, I use to average my trades. When I use 
> maxopenpositions=7, I use to average my results every 7 trades.
>   > > > > Considering that, my trades in three months are not 70, but less ( 
> not exactly 70/7, but less than 70)
>   > > > > 
>   > > > > If I use maxopenposition=1, which is, invest all my capital every 
> trade, in three months I would have about 29 trades.
>   > > > > So I suppose I have to increase the IS period.. isn`t it?
>   > > > > 
>   > > > > 
>   > > > > --- In [email protected], "Bisto" <bistoman73@> wrote:
>   > > > > >
>   > > > > > What do you mean with "I don't have many buyings and sellings"?
>   > > > > > 
>   > > > > > If you have less than 30 trades in an IS period, IMHO, you are 
> using a too short period due to not statistical robustness --> WFA is 
> misleading, try a longer IS period
>   > > > > > 
>   > > > > > Bisto
>   > > > > > 
>   > > > > > --- In [email protected], "Gonzaga" <gonzagags@> wrote:
>   > > > > > >
>   > > > > > > Thanks for the answers
>   > > > > > > To Keith McCombs :
>   > > > > > > 
>   > > > > > > I use 3 months IS test and 1 month step, this is, 1 month OS 
> test. My system is an end-of day-system, so I don't have many buyings and 
> sellings.. 
>   > > > > > > Perhaps I should make bigger the IS period?
>   > > > > > > 
>   > > > > > > anyway, my parameter behaves well in any period. Of course it 
> is an optimized variable, but it doesn't fail in ten years, in none of those 
> ten years, over 500 stocks.. a very long period..
>   > > > > > > So, couldn't it be better, on the long run, than the parameters 
> optimized with the WF study?
>   > > > > > > (In fact, I am using it now, the optimized variable)
>   > > > > > > That's my real question..
>   > > > > > > 
>   > > > > > > To dloyer123:
>   > > > > > > I haven't understood the meaning of the Walk Forward Efficency, 
> and seems interesting.
>   > > > > > > can you explain it better, please..?
>   > > > > > > 
>   > > > > > > 
>   > > > > > > 
>   > > > > > > --- In [email protected], "dloyer123" <dloyer123@> 
> wrote:
>   > > > > > > >
>   > > > > > > > I have had similar experiences. I like to use WFT to estimate 
> what Pardo call's his "Walk Forward Efficency", or the ratio of the out of 
> sample WF profits to just optimizing over the entire time period. 
>   > > > > > > > 
>   > > > > > > > A good system should have as high a WFE as posible. Systems 
> with a poor WFE tend to do poorly in live trading.
>   > > > > > > > 
>   > > > > > > > If you have a parm set that works well over a long period of 
> live trading, then you are doing well!
>   > > > > > > >
>   > > > > > >
>   > > > > >
>   > > > >
>   > > >
>   > >
>   >
>


Reply via email to